Standard BioTools Price to Book Ratio 2010-2025 | LAB
Historical price to book ratio values for Standard BioTools (LAB) over the last 10 years. The current price to book ratio for Standard BioTools as of June 23, 2025 is 0.88.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Standard BioTools Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-23 | 1.23 | 1.03 | |
| 2025-03-31 | 1.08 | $1.20 | 0.90 |
| 2024-12-31 | 1.75 | $1.25 | 1.40 |
| 2024-09-30 | 1.93 | $1.31 | 1.47 |
| 2024-06-30 | 1.77 | $1.37 | 1.29 |
| 2024-03-31 | 2.71 | $1.52 | 1.79 |
| 2023-12-31 | 2.21 | $2.03 | 1.09 |
| 2023-09-30 | 2.90 | $2.26 | 1.28 |
| 2023-06-30 | 1.93 | $2.50 | 0.77 |
| 2023-03-31 | 1.95 | $2.72 | 0.72 |
| 2022-12-31 | 1.17 | $2.89 | 0.40 |
| 2022-09-30 | 1.10 | $3.14 | 0.35 |
| 2022-06-30 | 1.60 | $3.48 | 0.46 |
| 2022-03-31 | 3.59 | $0.29 | 12.53 |
| 2021-12-31 | 3.92 | $1.23 | 3.19 |
| 2021-09-30 | 6.59 | $1.30 | 5.07 |
| 2021-06-30 | 6.16 | $1.44 | 4.29 |
| 2021-03-31 | 4.52 | $1.64 | 2.76 |
| 2020-12-31 | 6.00 | $1.87 | 3.22 |
| 2020-09-30 | 7.43 | $2.05 | 3.62 |
| 2020-06-30 | 4.01 | $1.86 | 2.15 |
| 2020-03-31 | 2.54 | $2.00 | 1.27 |
| 2019-12-31 | 3.48 | $2.20 | 1.58 |
| 2019-09-30 | 4.63 | $2.34 | 1.98 |
| 2019-06-30 | 12.32 | $2.49 | 4.95 |
| 2019-03-31 | 13.29 | $2.64 | 5.03 |
| 2018-12-31 | 8.62 | $1.46 | 5.90 |
| 2018-09-30 | 7.49 | $0.57 | 13.14 |
| 2018-06-30 | 5.96 | $0.89 | 6.70 |
| 2018-03-31 | 5.84 | $1.25 | 4.68 |
| 2017-12-31 | 5.89 | $0.80 | 7.38 |
| 2017-09-30 | 5.04 | $1.01 | 4.98 |
| 2017-06-30 | 4.04 | $0.81 | 4.96 |
| 2017-03-31 | 5.69 | $1.31 | 4.33 |
| 2016-12-31 | 7.28 | $1.82 | 3.99 |
| 2016-09-30 | 8.01 | $2.33 | 3.43 |
| 2016-06-30 | 9.03 | $2.90 | 3.11 |
| 2016-03-31 | 8.07 | $3.43 | 2.36 |
| 2015-12-31 | 10.81 | $3.98 | 2.71 |
| 2015-09-30 | 8.11 | $4.31 | 1.88 |
| 2015-06-30 | 24.20 | $4.61 | 5.25 |
| 2015-03-31 | 42.10 | $4.96 | 8.49 |
| 2014-12-31 | 33.73 | $5.31 | 6.36 |
| 2014-09-30 | 24.50 | $5.47 | 4.48 |
| 2014-06-30 | 29.40 | $5.75 | 5.12 |
| 2014-03-31 | 44.07 | $5.98 | 7.37 |
| 2013-12-31 | 38.28 | $3.74 | 10.25 |
| 2013-09-30 | 21.94 | $3.79 | 5.79 |
| 2013-06-30 | 17.46 | $3.86 | 4.52 |
| 2013-03-31 | 18.51 | $3.94 | 4.70 |
| 2012-12-31 | 14.31 | $4.01 | 3.57 |
| 2012-09-30 | 17.00 | $4.11 | 4.14 |
| 2012-06-30 | 15.04 | $2.37 | 6.34 |
| 2012-03-31 | 15.73 | $2.53 | 6.21 |
| 2011-12-31 | 13.16 | $2.80 | 4.70 |
| 2011-09-30 | 13.93 | $2.92 | 4.76 |
| 2011-06-30 | 16.77 | $3.12 | 5.38 |
| 2011-03-31 | 14.31 | $3.50 | 4.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.399B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.769B | 58.23 |
| Hims & Hers Health (HIMS) | United States | $14.374B | 149.35 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Phreesia (PHR) | United States | $1.560B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Evolent Health (EVH) | United States | $1.086B | 92.50 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |